Tasly Pharmaceutical Group Co., Ltd
600535
Rankning i aktier
#4771
Tasly Pharmaceutical Group Co., Ltd., a company founded in 1994 and based in... Tasly Pharmaceutical Group Co., Ltd., a company founded in 1994 and based in Tianjin, China, is actively engaged in the biological medicine, health, and medical service industries within China. Its extensive product catalog encompasses a wide range of goods, including both traditional herbal and modern chemical medicines, alongside various health supplements. The firm also supplies key pharmaceutical ingredients (APIs), concentrated herbal granules, herbal extracts, and a diverse selection of tea products. Beyond its core pharmaceutical offerings, Tasly manufactures cosmetic lines featuring items such as moisturizing lotions, facial creams, eye creams, and cleansing foams. Additionally, its consumer goods division provides daily hygiene essentials like sanitary and carefree pads, in addition to specialized soaps made with honey-propolis and pollen. The company further distributes medical equipment, including different types of massage devices like tappers and cushions, as well as circulation-enhancing machines. Tasly's market presence extends globally, with significant exports directed to the United States, Russia, and numerous countries across Europe, Africa, and other parts of Asia.
Aktiekurs
$2.05
Marknadsvärde
$3.07B
Förändring (1 dag)
-1.37%
Förändring (1 år)
-7.80%
Land
CN
Handel Tasly Pharmaceutical Group Co., Ltd (600535)
Kategori
Healthcare
Vinst för Tasly Pharmaceutical Group Co., Ltd (600535)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Tasly Pharmaceutical Group Co., Ltd är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Tasly Pharmaceutical Group Co., Ltd från 2001 till 2026
Vinst vid slutet av varje år
| År | Vinst | Ändra |
|---|---|---|
| 2025 | $192.27M | 31.32% |
| 2024 | $146.41M | -15.13% |
| 2023 | $172.51M | -809.84% |
| 2022 | $-24.30M | -105.67% |
| 2021 | $428.51M | 92.12% |
| 2020 | $223.04M | 16.70% |
| 2019 | $191.12M | -32.79% |
| 2018 | $284.34M | 6.54% |
| 2017 | $266.90M | 23.84% |
| 2016 | $215.52M | -22.05% |
| 2015 | $276.48M | -1.18% |
| 2014 | $279.80M | 19.89% |
| 2013 | $233.39M | 34.76% |
| 2012 | $173.19M | 38.94% |
| 2011 | $124.65M | 48.07% |
| 2010 | $84.18M | 44.00% |
| 2009 | $58.46M | 26.80% |
| 2008 | $46.10M | 49.47% |
| 2007 | $30.84M | -8.16% |
| 2006 | $33.58M | 16.86% |
| 2005 | $28.74M | 10.44% |
| 2004 | $26.02M | 22.03% |
| 2003 | $21.32M | 21.82% |
| 2002 | $17.50M | 12.42% |
| 2001 | $15.57M | 0.00% |
Vinst för liknande företag eller konkurrenter
| Företag | Vinst | Skillnad i vinst | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
